Question explored with the scientific record
Conversation so far
- 1 Cause of fnd and treatments
- 2 What are the risks of misdiagnosis or delaying FND treatment?
- 3 Does early FND treatment shorten time to diagnosis or improve outcomes?
Answered on this page ↓
Does early FND treatment shorten time to diagnosis or improve outcomes?
The short version: the evidence does not answer whether early FND treatment shortens time to diagnosis or improves outcomes. No study in this retrieval tests that question.
The retrieved evidence contains nothing that compares early versus late treatment for FND. One study of a one-week physical therapy protocol for functional movement disorders showed that 60.4% of treated patients had good long-term outcomes versus 21.9% of controls [3]. But that study did not measure time to diagnosis or compare early versus late treatment. It compared a specific intervention to usual care, not timing.
A separate study of cognitive behavioral therapy for psychogenic nonepileptic seizures found reduced seizure frequency and improved psychiatric outcomes over 12 weeks [2]. Again, no comparison of early versus delayed treatment. The study enrolled patients who already had a diagnosis, not patients diagnosed early versus late.
The previous answer's Italian registry data showed that diagnostic delay is common, especially in adolescents, with a mean of 4.4 doctors seen before diagnosis [1]. But that registry did not measure whether earlier treatment would have changed outcomes. It documented the delay, not its consequences.
The evidence here simply does not include a trial that randomizes patients to early diagnosis and treatment versus delayed diagnosis and treatment, or that tracks outcomes by time to diagnosis. Without that design, the question remains unanswered. The claim that early treatment improves outcomes is plausible on mechanism, but it is not proven by any study in this retrieval.
My call: the evidence does not show whether early FND treatment shortens time to diagnosis or improves outcomes. Confidence: not clear.
Sources used 3
-
Subgroup analysis of the non-interventional study VIVALDI: Agomelatine in treatment-naïve patients, in combination therapy and after treatment switch
A large German real-world, 12-week, non-interventional analysis (VIVALDI) of agomelatine in major depressive disorder across three subgroups—treatment-naïve mono-therapy, combination therapy, and switch from prior antidepressants—demonstrates early and sustained improvement in d…
DOI: 10.3109/13651501.2014.892138 -
Cognitive behavioral therapy for psychogenic nonepileptic seizures
Prospective clinical trial evaluating a Beckian-based cognitive behavioral therapy (CBT) program for psychogenic nonepileptic seizures (PNES) in adults, showing reduced PNES frequency and improved psychiatric and psychosocial outcomes over 12 weeks, with feasibility of tele-CBT …
DOI: 10.1016/j.yebeh.2009.02.016 -
Functional movement disorders: Successful treatment with a physical therapy rehabilitation protocol
A historical cohort study found that a one-week intensive motor-reprogramming physical therapy protocol for functional movement disorders produced markedly improved or remitted outcomes in 73.3% by physician assessment at week end and 60.4% at long-term follow-up, compared with …
DOI: 10.1016/j.parkreldis.2011.10.011